PPD, Inc. – NASDAQ:PPD
PPD stock price today
$47.28
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
PPD stock price quarterly change
+0.11%
quarter
PPD stock price yearly change
+33.79%
year
PPD key metrics
Market Cap | N/A |
Enterprise value | 19.85B |
P/E | 45.62 |
EV/Sales | 3.37 |
EV/EBITDA | 21.27 |
Price/Sales | 2.82 |
Price/Book | -39.14 |
PEG ratio | 0.38 |
EPS | 1.05 |
Revenue | 5.87B |
EBITDA | 933.11M |
Income | 364.05M |
Revenue Q/Q | 26.50% |
Revenue Y/Y | 34.71% |
Profit margin | 6.19% |
Oper. margin | 11.13% |
Gross margin | 37.27% |
EBIT margin | 11.13% |
EBITDA margin | 15.87% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freePPD stock price history
PPD stock forecast
PPD financial statements
| Dec 2020 | 1.36B | 100.09M | 7.34% |
|---|---|---|---|
| Mar 2021 | 1.37B | 45.88M | 3.33% |
| Jun 2021 | 1.57B | 51.00M | 3.24% |
| Sep 2021 | 1.56B | 167.07M | 10.7% |
| 2021-02-24 | 0.36 | 0.39 |
|---|---|---|
| 2021-04-27 | 0.31 | 0.35 |
| 2021-07-28 | 0.34 | 0.36 |
| 2021-10-27 | 0.35 | 0.4 |
| Dec 2020 | 6293843000 | 7.04B | 111.86% |
|---|---|---|---|
| Mar 2021 | 6467998000 | 7.10B | 109.9% |
| Jun 2021 | 6749142000 | 7.29B | 108.04% |
| Sep 2021 | 7028017000 | 7.45B | 106.04% |
| Dec 2020 | -17.13M | -34.11M | -25.58M |
|---|---|---|---|
| Mar 2021 | 148.15M | -28.03M | -58.98M |
| Jun 2021 | 146.88M | -32.60M | -4.55M |
| Sep 2021 | 291.35M | -37.89M | -7.01M |
PPD alternative data
| Aug 2023 | 30,000 |
|---|---|
| Sep 2023 | 30,000 |
| Oct 2023 | 30,000 |
| Nov 2023 | 30,000 |
| Dec 2023 | 30,000 |
| Jan 2024 | 30,000 |
| Feb 2024 | 30,000 |
| Mar 2024 | 30,000 |
| Apr 2024 | 30,000 |
| May 2024 | 30,000 |
| Jun 2024 | 30,000 |
| Jul 2024 | 30,000 |
PPD other data
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2020 | 0 | 84948910 |
| Feb 2021 | 0 | 77065 |
| Mar 2021 | 0 | 191175 |
| Apr 2021 | 0 | 100000 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Sale | SIMMONS DAVID S director, officer: Chief Execut.. | Common Stock | 100,000 | $42 | $4,200,000 | ||
Option | JOHNSTON DAVID MICHAEL officer: See Rema.. | Common Stock | 21,598 | $10.59 | $228,723 | ||
Sale | JOHNSTON DAVID MICHAEL officer: See Rema.. | Common Stock | 21,598 | N/A | N/A | ||
Option | JOHNSTON DAVID MICHAEL officer: See Rema.. | Stock Option (Right to Buy) | 21,598 | N/A | N/A | ||
Sale | SIMMONS DAVID S director, officer: Chief Execut.. | Common Stock | 22,935 | N/A | N/A | ||
Option | DONOVAN GLEN officer: Chief Accounting Officer | Common Stock | 16,347 | N/A | N/A | ||
Sale | DONOVAN GLEN officer: Chief Accounting Officer | Common Stock | 16,347 | $10.59 | $173,115 | ||
Option | DONOVAN GLEN officer: Chief Accounting Officer | Stock Option (Right to Buy) | 16,347 | N/A | N/A | ||
Option | GARROW RONALD E officer: See Remarks | Common Stock | 69,401 | $16.79 | $1,164,896 | ||
Option | JOHNSTON DAVID MICHAEL officer: See Rema.. | Common Stock | 21,597 | $10.59 | $228,712 |
| Patent |
|---|
Application Filling date: 12 Nov 2019 Issue date: 14 May 2020 |
| Quarter | Transcript |
|---|---|
| Q3 2021 28 Oct 2021 | Q3 2021 Earnings Call Transcript |
| Q2 2021 31 Jul 2021 | Q2 2021 Earnings Call Transcript |
| Q1 2021 28 Apr 2021 | Q1 2021 Earnings Call Transcript |
| Q4 2020 25 Feb 2021 | Q4 2020 Earnings Call Transcript |
-
What's the price of PPD stock today?
One share of PPD stock can currently be purchased for approximately $47.28.
-
When is PPD's next earnings date?
Unfortunately, PPD's (PPD) next earnings date is currently unknown.
-
Does PPD pay dividends?
No, PPD does not pay dividends.
-
What is PPD's stock symbol?
PPD, Inc. is traded on the NASDAQ under the ticker symbol "PPD".
-
What is PPD's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of PPD?
Shares of PPD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are PPD's key executives?
PPD's management team includes the following people:
- Mr. David S. Simmons Chairman & Chief Executive Officer(age: 60, pay: $3,420,000)
- Mr. Anshul Thakral Executive Vice President, Chief Commercial Officer & Pres of Evidera(age: 47, pay: $1,130,000)
- Mr. Christopher G. Scully Executive Vice President, Chief Financial Officer, Treasurer & Assistant Sec.(age: 54, pay: $1,000,000)
- Dr. David Michael Johnston Ph.D. Executive Vice President of Global Clinical Devel.(age: 56, pay: $788,870)
-
How many employees does PPD have?
As Jul 2024, PPD employs 30,000 workers.
-
When PPD went public?
PPD, Inc. is publicly traded company for more then 5 years since IPO on 6 Feb 2020.
-
What is PPD's official website?
The official website for PPD is ppd.com.
-
Where are PPD's headquarters?
PPD is headquartered at 929 North Front Street, Wilmington, NORTH CAROLINA.
-
How can i contact PPD?
PPD's mailing address is 929 North Front Street, Wilmington, NORTH CAROLINA and company can be reached via phone at +1 910 251 0081.
PPD company profile:
PPD, Inc.
ppd.comExchange:
NASDAQ
Full time employees:
30,000
Industry:
Drug Manufacturers - Specialty & Generic
Sector:
Healthcare
PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.
929 North Front Street
Wilmington, NORTH CAROLINA 28401-3331
Wilmington, NORTH CAROLINA 28401-3331
CIK: 0001793294
ISIN: US69355F1021
CUSIP: 69355F102
